Attend this 1-day C.E.L.for pharma course with Dr. Patrik Frei and learn:

  • The main valuation approaches, tools & techniques currently used in the pharma-biotech world.
  • Methodology for assessing the risk profile of a company prior to valuation.
  • An overview of different valuation methods used for life science companies and products.
  • How to calculate the value of a life sciences company with the Discounted Cash Flow method, comparables and exit valuation.
  • How to calculate the value of a compound in development, using the most commonly used tool, i.e. the risk-adjusted Net Present Value (rNPV).
  • How to structure the licensing deal between companies, covering issues such as milestone and royalty payments.

Additional Benefits

  • Gain practice in calculating the value of a phase II compound with an Excel-based valuation tool, which you can use when back in the office.
  • The audience of this course is always an interesting mix of executives from pharma, biotech and related (e.g. tech transfer) companies.

This 1-day course will be organized back-to-back with the Swiss Biotech Day.

The registration fee will amount to € 1 070 (+VAT) instead of to € 1 470 (+VAT) for members of the Swiss Biotech Association.

Location: Hotel Pullman Basel Europe, Clarastrasse 43, 4058 Basel

Event starts in
  • 85

  • 14

  • 31